Aspira Pathlab Stock Screener | Share Price & Fundamental Analysis
ASPIRA
Healthcare Service Provider
Screen Aspira Pathlab share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹66.00
▼
-0.93 (-1.39%)
Market Cap
₹66.31 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
9.41
EPS (TTM)
₹1.97
Dividend Yield
-
Debt to Equity
0.15
52W High
₹101.70
52W Low
₹51.52
Operating Margin
13.00%
Profit Margin
-
Revenue (TTM)
₹5.00
EBITDA
₹1.00
Net Income
-
Total Assets
₹18.00
Total Equity
₹12.00
Aspira Pathlab Share Price History - Stock Screener Chart
Screen ASPIRA historical share price movements with interactive charts. Analyze price trends and patterns.
Aspira Pathlab Company Profile - Fundamental Screener
Screen Aspira Pathlab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ASPIRA shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE500C01017
Aspira Pathlab Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ASPIRA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Total Assets | 18 | 15 |
| Current Assets | 5 | 4 |
| Fixed Assets | 7 | 7 |
| Liabilities | ||
| Total Liabilities | 18 | 15 |
| Current Liabilities | 3 | 3 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 12 | 10 |
| Share Capital | 10 | 10 |
| Reserves & Surplus | -3 | -5 |
Screen ASPIRA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Jun |
|---|---|---|---|---|---|---|---|
| Revenue | 5 | 6 | 6 | 6 | 5 | 4 | 3 |
| Expenses | 5 | 5 | 5 | 5 | 4 | 4 | 3 |
| EBITDA | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Operating Profit % | 13.00% | 16.00% | 11.00% | 21.00% | 6.00% | -5.00% | -17.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 0 | 1 | 0 | -1 | -1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 0 | 1 | 0 | -1 | -1 |
| EPS | 0.41 | 0.66 | 0.30 | 0.96 | 0.05 | -0.49 | -0.70 |
Aspira Pathlab Cash Flow Screener - Liquidity Fundamentals
Screen ASPIRA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March |
|---|---|---|
| Operating Activities | 2 | 1 |
| Investing Activities | 0 | 0 |
| Financing Activities | -1 | -1 |
| Net Cash Flow | 1 | 0 |
Screen ASPIRA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 18.39% | 18.39% | 18.39% | 18.55% | 18.55% | 18.72% | 18.72% | 18.90% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 60.16% | 60.28% | 60.46% | 60.28% | 61.26% | 59.15% | 55.71% | 51.99% |
| Other Holding | 21.45% | 21.33% | 21.15% | 21.18% | 20.19% | 22.13% | 25.57% | 29.11% |
| Shareholder Count | 1,755 | 1,770 | 1,741 | 1,593 | 1,706 | 1,695 | 1,512 | 1,351 |
Aspira Pathlab Dividend Screener - Share Yield Analysis
Screen ASPIRA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Aspira Pathlab Index Membership - Market Screener Classification
Screen ASPIRA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Aspira Pathlab Market Events Screener - Corporate Actions
Screen ASPIRA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 27.67% | ||
| Annual General Meeting | NA | -1.79% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -0.33% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -6.20% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | -12.33% |
| 2025-02-07 | 2025-02-07 | Quarterly Result Announcement | NA | -9.00% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 23.16% |
| 2016-11-16 | 2016-11-16 | Change Of Name | NA | - |
Aspira Pathlab Competitors Screener - Peer Comparison
Screen ASPIRA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 25,297 | 46.00 | 2,555 | 11.28% | 492 | 60.03 |
| Vijaya Diagnostic Centre | 10,708 | 71.76 | 700 | 23.06% | 144 | 57.20 |
| Metropolis Healthcare | 9,830 | 62.94 | 1,346 | 10.64% | 146 | 46.81 |
| Thyrocare Technologies | 7,110 | 56.03 | 702 | 20.80% | 91 | 48.33 |
| Nephrocare Health Services | 4,574 | 70.14 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,402 | 27.63 | 743 | 16.70% | 78 | 48.50 |
| Suraksha Diagnostic | 1,423 | 44.85 | 256 | 15.11% | 31 | 41.02 |
| One Global Service Provider | 1,241 | 28.22 | 148 | 134.60% | 19 | 59.79 |
| 3B BlackBio DX | 1,220 | 24.50 | 112 | 28.72% | 48 | 57.22 |
| Sastasundar Ventures | 938 | -103.74 | 1,171 | -18.47% | -134 | 38.32 |
Aspira Pathlab Company Announcements - News Screener
Screen ASPIRA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-04 | Closure of Trading Window | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-11-12 | Standalone Financial Results And Limited Review Report As On September 30 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On November 12 2025 | View |
| 2025-11-04 | Board Meeting Intimation for The Board Meeting To Be Held On November 12 2025 | View |
| 2025-10-13 | Announcement under Regulation 30 (LODR)-Open Offer - Updates | View |
| 2025-10-13 | Draft Letter of Offer | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-06 | Disclosure Regarding Detailed Public Statement ("DPS") In Relation To The Open Offer To The Public Shareholders | View |
| 2025-10-06 | Detailed Public Statement | View |
| 2025-09-27 | Announcement under Regulation 30 (LODR)-Cessation | View |
| 2025-09-26 | Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer | View |
| 2025-09-26 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-09-26 | Appointment Of Secretarial Auditor Of The Company | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-26 | Public Announcement - Open Offer | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |